Mulberry Biotherapeutics
PrivateLast Round
M&A
Oct 1, 2025
Company Overview
Mulberry Biotherapeutics is a biotechnology company developing bacteria-mediated immunotherapies for the treatment of rare, slow-growing tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mulberry Biotherapeutics Comparables
Compare Mulberry Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santo Therapeutics | 78% | |
| Recursion Pharmaceuticals | 78% | |
| Guangzhou Sinogen Pharmaceutical Co., Ltd. | 78% |
Mulberry Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Oct 1, 2025 | ||||
| VC Round | Apr 20, 2021 |
Mulberry Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Community Impact Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 6106% MoM, from 16 to 993.
- Apr 20, 2021
Secured funding from Community Impact Ventures.
Mulberry Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mulberry Biotherapeutics's valuation, stock price, and market status.
Is Mulberry Biotherapeutics a public or private company?
Mulberry Biotherapeutics is a private company.
What is the current stock price of Mulberry Biotherapeutics?
Mulberry Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Mulberry Biotherapeutics worth (valuation)?
Valuation information for Mulberry Biotherapeutics is not publicly available.
Can I buy Mulberry Biotherapeutics stock?
Mulberry Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mulberry Biotherapeutics's last funding round?
Mulberry Biotherapeutics's most recent funding round was M&A on October 1, 2025.
Who are the main investors in Mulberry Biotherapeutics?
Key investors in Mulberry Biotherapeutics include Community Impact Ventures.
Will Mulberry Biotherapeutics IPO soon?
No public IPO plans have been announced for Mulberry Biotherapeutics.
How can I track Mulberry Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mulberry Biotherapeutics's secondary market activity and sign up for updates.